nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—Vismodegib—skin cancer	0.188	0.268	CbGbCtD
Valsartan—SLCO1B3—Docetaxel—skin cancer	0.16	0.228	CbGbCtD
Valsartan—ALB—Vemurafenib—skin cancer	0.149	0.212	CbGbCtD
Valsartan—CYP2C9—Vismodegib—skin cancer	0.102	0.145	CbGbCtD
Valsartan—ALB—Fluorouracil—skin cancer	0.0669	0.0953	CbGbCtD
Valsartan—CYP2C9—Fluorouracil—skin cancer	0.0361	0.0514	CbGbCtD
Valsartan—Shock—Imiquimod—skin cancer	0.000613	0.00205	CcSEcCtD
Valsartan—Nervous system disorder—Imiquimod—skin cancer	0.000611	0.00205	CcSEcCtD
Valsartan—Upper respiratory tract infection—Temozolomide—skin cancer	0.00061	0.00204	CcSEcCtD
Valsartan—Skin disorder—Imiquimod—skin cancer	0.000605	0.00203	CcSEcCtD
Valsartan—Erectile dysfunction—Temozolomide—skin cancer	0.000604	0.00203	CcSEcCtD
Valsartan—Photosensitivity reaction—Temozolomide—skin cancer	0.000599	0.00201	CcSEcCtD
Valsartan—Anorexia—Imiquimod—skin cancer	0.000593	0.00199	CcSEcCtD
Valsartan—Infestation NOS—Temozolomide—skin cancer	0.000585	0.00196	CcSEcCtD
Valsartan—Infestation—Temozolomide—skin cancer	0.000585	0.00196	CcSEcCtD
Valsartan—Hepatitis—Dactinomycin—skin cancer	0.000581	0.00195	CcSEcCtD
Valsartan—Pharyngitis—Dactinomycin—skin cancer	0.000576	0.00193	CcSEcCtD
Valsartan—Swelling—Docetaxel—skin cancer	0.000572	0.00192	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000567	0.0019	CcSEcCtD
Valsartan—Insomnia—Imiquimod—skin cancer	0.000563	0.00189	CcSEcCtD
Valsartan—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000562	0.00188	CcSEcCtD
Valsartan—Paraesthesia—Imiquimod—skin cancer	0.000559	0.00187	CcSEcCtD
Valsartan—Dyspnoea—Imiquimod—skin cancer	0.000555	0.00186	CcSEcCtD
Valsartan—Somnolence—Imiquimod—skin cancer	0.000553	0.00186	CcSEcCtD
Valsartan—Photosensitivity reaction—Fluorouracil—skin cancer	0.000552	0.00185	CcSEcCtD
Valsartan—Alopecia—Bleomycin—skin cancer	0.00055	0.00184	CcSEcCtD
Valsartan—Sinusitis—Temozolomide—skin cancer	0.000549	0.00184	CcSEcCtD
Valsartan—Dyspepsia—Imiquimod—skin cancer	0.000548	0.00184	CcSEcCtD
Valsartan—Decreased appetite—Imiquimod—skin cancer	0.000541	0.00181	CcSEcCtD
Valsartan—Infestation NOS—Fluorouracil—skin cancer	0.000539	0.00181	CcSEcCtD
Valsartan—Infestation—Fluorouracil—skin cancer	0.000539	0.00181	CcSEcCtD
Valsartan—Hypersensitivity—Vemurafenib—skin cancer	0.000538	0.0018	CcSEcCtD
Valsartan—Gastrointestinal disorder—Imiquimod—skin cancer	0.000537	0.0018	CcSEcCtD
Valsartan—Fatigue—Imiquimod—skin cancer	0.000537	0.0018	CcSEcCtD
Valsartan—Atrial fibrillation—Docetaxel—skin cancer	0.000533	0.00179	CcSEcCtD
Valsartan—Renal impairment—Docetaxel—skin cancer	0.00053	0.00178	CcSEcCtD
Valsartan—Dermatitis bullous—Docetaxel—skin cancer	0.000528	0.00177	CcSEcCtD
Valsartan—Haemoglobin—Temozolomide—skin cancer	0.000528	0.00177	CcSEcCtD
Valsartan—Haemorrhage—Temozolomide—skin cancer	0.000525	0.00176	CcSEcCtD
Valsartan—Hepatitis—Temozolomide—skin cancer	0.000525	0.00176	CcSEcCtD
Valsartan—Asthenia—Vemurafenib—skin cancer	0.000524	0.00176	CcSEcCtD
Valsartan—Pharyngitis—Temozolomide—skin cancer	0.000521	0.00175	CcSEcCtD
Valsartan—Urinary tract disorder—Temozolomide—skin cancer	0.000519	0.00174	CcSEcCtD
Valsartan—Cardiac failure—Docetaxel—skin cancer	0.000517	0.00173	CcSEcCtD
Valsartan—Pruritus—Vemurafenib—skin cancer	0.000516	0.00173	CcSEcCtD
Valsartan—Connective tissue disorder—Temozolomide—skin cancer	0.000516	0.00173	CcSEcCtD
Valsartan—Urethral disorder—Temozolomide—skin cancer	0.000515	0.00173	CcSEcCtD
Valsartan—Alopecia—Dactinomycin—skin cancer	0.000513	0.00172	CcSEcCtD
Valsartan—Gastrointestinal pain—Imiquimod—skin cancer	0.000509	0.00171	CcSEcCtD
Valsartan—Epistaxis—Fluorouracil—skin cancer	0.000508	0.0017	CcSEcCtD
Valsartan—Hyponatraemia—Docetaxel—skin cancer	0.000507	0.0017	CcSEcCtD
Valsartan—Sinusitis—Fluorouracil—skin cancer	0.000506	0.0017	CcSEcCtD
Valsartan—Diarrhoea—Vemurafenib—skin cancer	0.000499	0.00167	CcSEcCtD
Valsartan—Urticaria—Imiquimod—skin cancer	0.000495	0.00166	CcSEcCtD
Valsartan—Abdominal pain—Imiquimod—skin cancer	0.000492	0.00165	CcSEcCtD
Valsartan—Cardiac disorder—Temozolomide—skin cancer	0.000487	0.00163	CcSEcCtD
Valsartan—Haemoglobin—Fluorouracil—skin cancer	0.000486	0.00163	CcSEcCtD
Valsartan—Rhinitis—Fluorouracil—skin cancer	0.000485	0.00163	CcSEcCtD
Valsartan—Haemorrhage—Fluorouracil—skin cancer	0.000484	0.00162	CcSEcCtD
Valsartan—Dizziness—Vemurafenib—skin cancer	0.000483	0.00162	CcSEcCtD
Valsartan—Pharyngitis—Fluorouracil—skin cancer	0.00048	0.00161	CcSEcCtD
Valsartan—Angiopathy—Temozolomide—skin cancer	0.000476	0.0016	CcSEcCtD
Valsartan—Immune system disorder—Temozolomide—skin cancer	0.000474	0.00159	CcSEcCtD
Valsartan—Mediastinal disorder—Temozolomide—skin cancer	0.000473	0.00159	CcSEcCtD
Valsartan—Cough—Bleomycin—skin cancer	0.000473	0.00159	CcSEcCtD
Valsartan—Vomiting—Vemurafenib—skin cancer	0.000464	0.00156	CcSEcCtD
Valsartan—Alopecia—Temozolomide—skin cancer	0.000464	0.00156	CcSEcCtD
Valsartan—Chest pain—Bleomycin—skin cancer	0.000461	0.00155	CcSEcCtD
Valsartan—Myalgia—Bleomycin—skin cancer	0.000461	0.00155	CcSEcCtD
Valsartan—Abdominal pain upper—Docetaxel—skin cancer	0.000461	0.00155	CcSEcCtD
Valsartan—Orthostatic hypotension—Docetaxel—skin cancer	0.000461	0.00155	CcSEcCtD
Valsartan—Rash—Vemurafenib—skin cancer	0.00046	0.00154	CcSEcCtD
Valsartan—Mental disorder—Temozolomide—skin cancer	0.00046	0.00154	CcSEcCtD
Valsartan—Dermatitis—Vemurafenib—skin cancer	0.00046	0.00154	CcSEcCtD
Valsartan—Hypersensitivity—Imiquimod—skin cancer	0.000459	0.00154	CcSEcCtD
Valsartan—Headache—Vemurafenib—skin cancer	0.000457	0.00153	CcSEcCtD
Valsartan—Malnutrition—Temozolomide—skin cancer	0.000457	0.00153	CcSEcCtD
Valsartan—Cramp muscle—Docetaxel—skin cancer	0.000455	0.00152	CcSEcCtD
Valsartan—Dysgeusia—Temozolomide—skin cancer	0.000448	0.0015	CcSEcCtD
Valsartan—Asthenia—Imiquimod—skin cancer	0.000447	0.0015	CcSEcCtD
Valsartan—Anaphylactic shock—Bleomycin—skin cancer	0.000442	0.00148	CcSEcCtD
Valsartan—Oedema—Bleomycin—skin cancer	0.000442	0.00148	CcSEcCtD
Valsartan—Back pain—Temozolomide—skin cancer	0.000442	0.00148	CcSEcCtD
Valsartan—Pruritus—Imiquimod—skin cancer	0.00044	0.00148	CcSEcCtD
Valsartan—Infection—Bleomycin—skin cancer	0.000439	0.00147	CcSEcCtD
Valsartan—Nausea—Vemurafenib—skin cancer	0.000434	0.00145	CcSEcCtD
Valsartan—Thrombocytopenia—Bleomycin—skin cancer	0.000433	0.00145	CcSEcCtD
Valsartan—Vision blurred—Temozolomide—skin cancer	0.000431	0.00144	CcSEcCtD
Valsartan—Myalgia—Dactinomycin—skin cancer	0.00043	0.00144	CcSEcCtD
Valsartan—Alopecia—Fluorouracil—skin cancer	0.000428	0.00143	CcSEcCtD
Valsartan—Diarrhoea—Imiquimod—skin cancer	0.000426	0.00143	CcSEcCtD
Valsartan—Anorexia—Bleomycin—skin cancer	0.000422	0.00141	CcSEcCtD
Valsartan—Angioedema—Temozolomide—skin cancer	0.000418	0.0014	CcSEcCtD
Valsartan—Hypotension—Bleomycin—skin cancer	0.000413	0.00139	CcSEcCtD
Valsartan—Oedema—Dactinomycin—skin cancer	0.000412	0.00138	CcSEcCtD
Valsartan—Dizziness—Imiquimod—skin cancer	0.000412	0.00138	CcSEcCtD
Valsartan—Vertigo—Temozolomide—skin cancer	0.000411	0.00138	CcSEcCtD
Valsartan—Infection—Dactinomycin—skin cancer	0.00041	0.00137	CcSEcCtD
Valsartan—Neutropenia—Docetaxel—skin cancer	0.000408	0.00137	CcSEcCtD
Valsartan—Palpitations—Temozolomide—skin cancer	0.000404	0.00135	CcSEcCtD
Valsartan—Thrombocytopenia—Dactinomycin—skin cancer	0.000404	0.00135	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000403	0.00135	CcSEcCtD
Valsartan—Cough—Temozolomide—skin cancer	0.000399	0.00134	CcSEcCtD
Valsartan—Paraesthesia—Bleomycin—skin cancer	0.000397	0.00133	CcSEcCtD
Valsartan—Vision blurred—Fluorouracil—skin cancer	0.000397	0.00133	CcSEcCtD
Valsartan—Vomiting—Imiquimod—skin cancer	0.000396	0.00133	CcSEcCtD
Valsartan—Dyspnoea—Bleomycin—skin cancer	0.000394	0.00132	CcSEcCtD
Valsartan—Anorexia—Dactinomycin—skin cancer	0.000393	0.00132	CcSEcCtD
Valsartan—Rash—Imiquimod—skin cancer	0.000393	0.00132	CcSEcCtD
Valsartan—Dermatitis—Imiquimod—skin cancer	0.000392	0.00132	CcSEcCtD
Valsartan—Headache—Imiquimod—skin cancer	0.00039	0.00131	CcSEcCtD
Valsartan—Arthralgia—Temozolomide—skin cancer	0.000389	0.00131	CcSEcCtD
Valsartan—Myalgia—Temozolomide—skin cancer	0.000389	0.00131	CcSEcCtD
Valsartan—Infestation NOS—Docetaxel—skin cancer	0.000389	0.0013	CcSEcCtD
Valsartan—Infestation—Docetaxel—skin cancer	0.000389	0.0013	CcSEcCtD
Valsartan—Anxiety—Temozolomide—skin cancer	0.000388	0.0013	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000387	0.0013	CcSEcCtD
Valsartan—Decreased appetite—Bleomycin—skin cancer	0.000384	0.00129	CcSEcCtD
Valsartan—Renal failure—Docetaxel—skin cancer	0.000382	0.00128	CcSEcCtD
Valsartan—Dry mouth—Temozolomide—skin cancer	0.000381	0.00128	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000376	0.00126	CcSEcCtD
Valsartan—Oedema—Temozolomide—skin cancer	0.000373	0.00125	CcSEcCtD
Valsartan—Anaphylactic shock—Temozolomide—skin cancer	0.000373	0.00125	CcSEcCtD
Valsartan—Infection—Temozolomide—skin cancer	0.000371	0.00124	CcSEcCtD
Valsartan—Nausea—Imiquimod—skin cancer	0.00037	0.00124	CcSEcCtD
Valsartan—Epistaxis—Docetaxel—skin cancer	0.000367	0.00123	CcSEcCtD
Valsartan—Nervous system disorder—Temozolomide—skin cancer	0.000366	0.00123	CcSEcCtD
Valsartan—Thrombocytopenia—Temozolomide—skin cancer	0.000365	0.00122	CcSEcCtD
Valsartan—Skin disorder—Temozolomide—skin cancer	0.000362	0.00122	CcSEcCtD
Valsartan—Myalgia—Fluorouracil—skin cancer	0.000359	0.0012	CcSEcCtD
Valsartan—Chest pain—Fluorouracil—skin cancer	0.000359	0.0012	CcSEcCtD
Valsartan—Decreased appetite—Dactinomycin—skin cancer	0.000359	0.0012	CcSEcCtD
Valsartan—Fatigue—Dactinomycin—skin cancer	0.000356	0.00119	CcSEcCtD
Valsartan—Anorexia—Temozolomide—skin cancer	0.000356	0.00119	CcSEcCtD
Valsartan—Urticaria—Bleomycin—skin cancer	0.000351	0.00118	CcSEcCtD
Valsartan—Haemoglobin—Docetaxel—skin cancer	0.000351	0.00118	CcSEcCtD
Valsartan—Rhinitis—Docetaxel—skin cancer	0.00035	0.00117	CcSEcCtD
Valsartan—Haemorrhage—Docetaxel—skin cancer	0.000349	0.00117	CcSEcCtD
Valsartan—Hepatitis—Docetaxel—skin cancer	0.000349	0.00117	CcSEcCtD
Valsartan—Pharyngitis—Docetaxel—skin cancer	0.000347	0.00116	CcSEcCtD
Valsartan—Urinary tract disorder—Docetaxel—skin cancer	0.000345	0.00116	CcSEcCtD
Valsartan—Oedema—Fluorouracil—skin cancer	0.000344	0.00115	CcSEcCtD
Valsartan—Anaphylactic shock—Fluorouracil—skin cancer	0.000344	0.00115	CcSEcCtD
Valsartan—Connective tissue disorder—Docetaxel—skin cancer	0.000343	0.00115	CcSEcCtD
Valsartan—Urethral disorder—Docetaxel—skin cancer	0.000342	0.00115	CcSEcCtD
Valsartan—Infection—Fluorouracil—skin cancer	0.000342	0.00115	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00034	0.00114	CcSEcCtD
Valsartan—Insomnia—Temozolomide—skin cancer	0.000337	0.00113	CcSEcCtD
Valsartan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000337	0.00113	CcSEcCtD
Valsartan—Nervous system disorder—Fluorouracil—skin cancer	0.000337	0.00113	CcSEcCtD
Valsartan—Thrombocytopenia—Fluorouracil—skin cancer	0.000337	0.00113	CcSEcCtD
Valsartan—Paraesthesia—Temozolomide—skin cancer	0.000335	0.00112	CcSEcCtD
Valsartan—Dyspnoea—Temozolomide—skin cancer	0.000333	0.00112	CcSEcCtD
Valsartan—Somnolence—Temozolomide—skin cancer	0.000332	0.00111	CcSEcCtD
Valsartan—Dyspepsia—Temozolomide—skin cancer	0.000328	0.0011	CcSEcCtD
Valsartan—Anorexia—Fluorouracil—skin cancer	0.000328	0.0011	CcSEcCtD
Valsartan—Abdominal pain—Dactinomycin—skin cancer	0.000326	0.00109	CcSEcCtD
Valsartan—Hypersensitivity—Bleomycin—skin cancer	0.000326	0.00109	CcSEcCtD
Valsartan—Decreased appetite—Temozolomide—skin cancer	0.000324	0.00109	CcSEcCtD
Valsartan—Cardiac disorder—Docetaxel—skin cancer	0.000324	0.00109	CcSEcCtD
Valsartan—Gastrointestinal disorder—Temozolomide—skin cancer	0.000322	0.00108	CcSEcCtD
Valsartan—Fatigue—Temozolomide—skin cancer	0.000322	0.00108	CcSEcCtD
Valsartan—Hypotension—Fluorouracil—skin cancer	0.000321	0.00108	CcSEcCtD
Valsartan—Constipation—Temozolomide—skin cancer	0.000319	0.00107	CcSEcCtD
Valsartan—Asthenia—Bleomycin—skin cancer	0.000317	0.00106	CcSEcCtD
Valsartan—Angiopathy—Docetaxel—skin cancer	0.000317	0.00106	CcSEcCtD
Valsartan—Immune system disorder—Docetaxel—skin cancer	0.000315	0.00106	CcSEcCtD
Valsartan—Mediastinal disorder—Docetaxel—skin cancer	0.000315	0.00106	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000313	0.00105	CcSEcCtD
Valsartan—Pruritus—Bleomycin—skin cancer	0.000313	0.00105	CcSEcCtD
Valsartan—Insomnia—Fluorouracil—skin cancer	0.000311	0.00104	CcSEcCtD
Valsartan—Paraesthesia—Fluorouracil—skin cancer	0.000309	0.00104	CcSEcCtD
Valsartan—Alopecia—Docetaxel—skin cancer	0.000309	0.00103	CcSEcCtD
Valsartan—Dyspnoea—Fluorouracil—skin cancer	0.000306	0.00103	CcSEcCtD
Valsartan—Mental disorder—Docetaxel—skin cancer	0.000306	0.00103	CcSEcCtD
Valsartan—Somnolence—Fluorouracil—skin cancer	0.000306	0.00102	CcSEcCtD
Valsartan—Gastrointestinal pain—Temozolomide—skin cancer	0.000305	0.00102	CcSEcCtD
Valsartan—Malnutrition—Docetaxel—skin cancer	0.000304	0.00102	CcSEcCtD
Valsartan—Hypersensitivity—Dactinomycin—skin cancer	0.000304	0.00102	CcSEcCtD
Valsartan—Dyspepsia—Fluorouracil—skin cancer	0.000303	0.00101	CcSEcCtD
Valsartan—Decreased appetite—Fluorouracil—skin cancer	0.000299	0.001	CcSEcCtD
Valsartan—Dysgeusia—Docetaxel—skin cancer	0.000298	0.000998	CcSEcCtD
Valsartan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000297	0.000995	CcSEcCtD
Valsartan—Urticaria—Temozolomide—skin cancer	0.000296	0.000994	CcSEcCtD
Valsartan—Asthenia—Dactinomycin—skin cancer	0.000296	0.000992	CcSEcCtD
Valsartan—Abdominal pain—Temozolomide—skin cancer	0.000295	0.000989	CcSEcCtD
Valsartan—Back pain—Docetaxel—skin cancer	0.000294	0.000986	CcSEcCtD
Valsartan—Muscle spasms—Docetaxel—skin cancer	0.000292	0.00098	CcSEcCtD
Valsartan—Diarrhoea—Dactinomycin—skin cancer	0.000282	0.000946	CcSEcCtD
Valsartan—Vomiting—Bleomycin—skin cancer	0.000281	0.000943	CcSEcCtD
Valsartan—Rash—Bleomycin—skin cancer	0.000279	0.000935	CcSEcCtD
Valsartan—Dermatitis—Bleomycin—skin cancer	0.000279	0.000934	CcSEcCtD
Valsartan—Hypersensitivity—Temozolomide—skin cancer	0.000275	0.000922	CcSEcCtD
Valsartan—Urticaria—Fluorouracil—skin cancer	0.000273	0.000916	CcSEcCtD
Valsartan—Syncope—Docetaxel—skin cancer	0.000273	0.000914	CcSEcCtD
Valsartan—Palpitations—Docetaxel—skin cancer	0.000269	0.000901	CcSEcCtD
Valsartan—Asthenia—Temozolomide—skin cancer	0.000268	0.000898	CcSEcCtD
Valsartan—Loss of consciousness—Docetaxel—skin cancer	0.000267	0.000896	CcSEcCtD
Valsartan—Cough—Docetaxel—skin cancer	0.000265	0.00089	CcSEcCtD
Valsartan—Pruritus—Temozolomide—skin cancer	0.000264	0.000885	CcSEcCtD
Valsartan—Nausea—Bleomycin—skin cancer	0.000263	0.000881	CcSEcCtD
Valsartan—Vomiting—Dactinomycin—skin cancer	0.000262	0.000879	CcSEcCtD
Valsartan—Rash—Dactinomycin—skin cancer	0.00026	0.000872	CcSEcCtD
Valsartan—Arthralgia—Docetaxel—skin cancer	0.000259	0.000868	CcSEcCtD
Valsartan—Chest pain—Docetaxel—skin cancer	0.000259	0.000868	CcSEcCtD
Valsartan—Myalgia—Docetaxel—skin cancer	0.000259	0.000868	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000257	0.000862	CcSEcCtD
Valsartan—Diarrhoea—Temozolomide—skin cancer	0.000255	0.000856	CcSEcCtD
Valsartan—Hypersensitivity—Fluorouracil—skin cancer	0.000253	0.000849	CcSEcCtD
Valsartan—Dry mouth—Docetaxel—skin cancer	0.000253	0.000849	CcSEcCtD
Valsartan—Anaphylactic shock—Docetaxel—skin cancer	0.000248	0.000832	CcSEcCtD
Valsartan—Oedema—Docetaxel—skin cancer	0.000248	0.000832	CcSEcCtD
Valsartan—Dizziness—Temozolomide—skin cancer	0.000247	0.000827	CcSEcCtD
Valsartan—Infection—Docetaxel—skin cancer	0.000246	0.000827	CcSEcCtD
Valsartan—Nausea—Dactinomycin—skin cancer	0.000245	0.000822	CcSEcCtD
Valsartan—Shock—Docetaxel—skin cancer	0.000244	0.000819	CcSEcCtD
Valsartan—Nervous system disorder—Docetaxel—skin cancer	0.000243	0.000816	CcSEcCtD
Valsartan—Pruritus—Fluorouracil—skin cancer	0.000243	0.000816	CcSEcCtD
Valsartan—Thrombocytopenia—Docetaxel—skin cancer	0.000243	0.000815	CcSEcCtD
Valsartan—Skin disorder—Docetaxel—skin cancer	0.000241	0.000808	CcSEcCtD
Valsartan—Vomiting—Temozolomide—skin cancer	0.000237	0.000795	CcSEcCtD
Valsartan—Anorexia—Docetaxel—skin cancer	0.000237	0.000793	CcSEcCtD
Valsartan—Rash—Temozolomide—skin cancer	0.000235	0.000789	CcSEcCtD
Valsartan—Diarrhoea—Fluorouracil—skin cancer	0.000235	0.000789	CcSEcCtD
Valsartan—Dermatitis—Temozolomide—skin cancer	0.000235	0.000788	CcSEcCtD
Valsartan—Headache—Temozolomide—skin cancer	0.000234	0.000784	CcSEcCtD
Valsartan—Hypotension—Docetaxel—skin cancer	0.000232	0.000777	CcSEcCtD
Valsartan—Dizziness—Fluorouracil—skin cancer	0.000227	0.000762	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000226	0.000758	CcSEcCtD
Valsartan—Insomnia—Docetaxel—skin cancer	0.000224	0.000752	CcSEcCtD
Valsartan—Paraesthesia—Docetaxel—skin cancer	0.000223	0.000747	CcSEcCtD
Valsartan—Nausea—Temozolomide—skin cancer	0.000222	0.000743	CcSEcCtD
Valsartan—Dyspnoea—Docetaxel—skin cancer	0.000221	0.000742	CcSEcCtD
Valsartan—Somnolence—Docetaxel—skin cancer	0.000221	0.00074	CcSEcCtD
Valsartan—Vomiting—Fluorouracil—skin cancer	0.000219	0.000733	CcSEcCtD
Valsartan—Dyspepsia—Docetaxel—skin cancer	0.000218	0.000732	CcSEcCtD
Valsartan—Rash—Fluorouracil—skin cancer	0.000217	0.000727	CcSEcCtD
Valsartan—Dermatitis—Fluorouracil—skin cancer	0.000217	0.000726	CcSEcCtD
Valsartan—Decreased appetite—Docetaxel—skin cancer	0.000216	0.000723	CcSEcCtD
Valsartan—Headache—Fluorouracil—skin cancer	0.000215	0.000722	CcSEcCtD
Valsartan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000214	0.000718	CcSEcCtD
Valsartan—Fatigue—Docetaxel—skin cancer	0.000214	0.000717	CcSEcCtD
Valsartan—Constipation—Docetaxel—skin cancer	0.000212	0.000711	CcSEcCtD
Valsartan—Nausea—Fluorouracil—skin cancer	0.000204	0.000685	CcSEcCtD
Valsartan—Gastrointestinal pain—Docetaxel—skin cancer	0.000203	0.00068	CcSEcCtD
Valsartan—Abdominal pain—Docetaxel—skin cancer	0.000196	0.000658	CcSEcCtD
Valsartan—Hypersensitivity—Docetaxel—skin cancer	0.000183	0.000613	CcSEcCtD
Valsartan—Asthenia—Docetaxel—skin cancer	0.000178	0.000597	CcSEcCtD
Valsartan—Pruritus—Docetaxel—skin cancer	0.000176	0.000589	CcSEcCtD
Valsartan—Diarrhoea—Docetaxel—skin cancer	0.00017	0.000569	CcSEcCtD
Valsartan—Dizziness—Docetaxel—skin cancer	0.000164	0.00055	CcSEcCtD
Valsartan—Vomiting—Docetaxel—skin cancer	0.000158	0.000529	CcSEcCtD
Valsartan—Rash—Docetaxel—skin cancer	0.000156	0.000525	CcSEcCtD
Valsartan—Dermatitis—Docetaxel—skin cancer	0.000156	0.000524	CcSEcCtD
Valsartan—Headache—Docetaxel—skin cancer	0.000155	0.000521	CcSEcCtD
Valsartan—Nausea—Docetaxel—skin cancer	0.000147	0.000494	CcSEcCtD
